Evidence map›Paper›PMID 40714745›Full record

ArticleAngewandte Chemie (International ed. in English)2025

Total Synthesis of Feglymycin Using Umpolung Amide Synthesis.

Preston C Gourville, Jade A Bing, Rashanique D Quarels, Sergey V Tsukanov, Kenneth E Schwieter, Kazuyuki Tokumaru, Amanda B Stephens, Dawn M Makley, Bo Shen, Abigail N Smith and 1 more

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Total Synthesis of Feglymycin Using Umpolung Amide Synthesis.Angewandte Chemie (International ed. in English) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Preston C GourvilleDepartment of Chemistry, Institute of Chemical Biology, Vanderbilt University, Nashville, TN, USA.
Jade A BingDepartment of Chemistry, Institute of Chemical Biology, Vanderbilt University, Nashville, TN, USA.
Rashanique D QuarelsDepartment of Chemistry, Institute of Chemical Biology, Vanderbilt University, Nashville, TN, USA.
Sergey V TsukanovDepartment of Chemistry, Institute of Chemical Biology, Vanderbilt University, Nashville, TN, USA.
Kenneth E SchwieterDepartment of Chemistry, Institute of Chemical Biology, Vanderbilt University, Nashville, TN, USA.
Kazuyuki TokumaruDepartment of Chemistry, Institute of Chemical Biology, Vanderbilt University, Nashville, TN, USA.
Amanda B StephensDepartment of Chemistry, Institute of Chemical Biology, Vanderbilt University, Nashville, TN, USA.
Dawn M MakleyDepartment of Chemistry, Institute of Chemical Biology, Vanderbilt University, Nashville, TN, USA.
Bo ShenDepartment of Chemistry, Institute of Chemical Biology, Vanderbilt University, Nashville, TN, USA.
Abigail N SmithDepartment of Chemistry, Institute of Chemical Biology, Vanderbilt University, Nashville, TN, USA.
Jeffrey N JohnstonDepartment of Chemistry, Institute of Chemical Biology, Vanderbilt University, Nashville, TN, USA.ORCID 0000-0002-0885-636X

Funding

Studies in Amide and Peptide SynthesisR01GM063557 · NIGMS · VANDERBILT UNIVERSITY · PI JOHNSTON, JEFFREY NICHOLAS · 2002 to 2022
$4.5M
Application of New Amination Reactions to Natural Product and Nonnatural HeterocyR56GM063557 · NIGMS · VANDERBILT UNIVERSITY · PI JOHNSTON, JEFFREY NICHOLAS · 2008 to 2008
$292k
Development of Ryanodine Receptor 2 Selective ProbesF31HL151125 · NHLBI · VANDERBILT UNIVERSITY · PI SMITH, ABIGAIL · 2020 to 2021
$53k
Academic Pathways FellowshipACS Division of Organic ChemistryEli LillyNational Science FoundationNational Science Foundation Graduate Research Fellowship ProgramNHLBI NIH HHS F31 HL151125NIGMS NIH HHS R01 GM063557NIGMS NIH HHS R56 GM063557NIH HHS GM063557NIH HHS HL151125Vanderbilt University
6 · The paper itself

Abstract

The preparation of peptidic molecules is a mainstay of synthesis, creating new tools that advance chemical biology, catalysis, and drug discovery. Despite the wide adoption of methods for amide synthesis based on electrophilic acyl transfer reactions, significant limitations remain that restrict access to chemical space and plague accessible peptides with imperfect conservation of stereochemical information. These problems persist in key applications (i.e., solid phase peptide synthesis) where reagent excess can be used to drive maximal yield. As a general tactic, however, use of excess coupling agents that are often hazardous is unsustainable. Here we report the synthesis of the antiviral tridecapeptide feglymycin where half of the amides are formed using umpolung amide synthesis (UmAS) to replace conventional amide synthesis. Reliance on UmAS further allowed the enantioselective synthesis of each noncanonical residue from an inexpensive aldehyde. As a result, the most process-intensive components were simplified to a chiral Brønsted acid organocatalyst and potassium iodide/urea·hydrogen peroxide (KI/UHP). This solution-phase total synthesis illustrates the harmonious, strategic application of complementary amide synthesis methods, and it serves as a touchstone for the green synthesis of peptides composed of noncanonical amino amides.

Indexed as

AmidesAntiviral AgentsCatalysisMolecular StructureSolid-Phase Synthesis TechniquesStereoisomerismAmidesAntiviral AgentsAntiviralEnantioselective amide synthesisFeglymycinNatural product synthesisUmpolung amide synthesis

Identifiers

PMID40714745
PMCPMC12416467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.